5.30
price down icon7.57%   -0.434
after-market  After Hours:  5.21  -0.09   -1.70%
loading
NeuroBo Pharmaceuticals Inc stock is currently priced at $5.30, with a 24-hour trading volume of 63,371. It has seen a -7.57% decreased in the last 24 hours and a +66.67% rose in the past month. The chart indicates a potential bearish trend, as the stock is below the $5.70 pivot point. If it approaches the $5.18 support level, significant changes may occur.

NeuroBo Pharmaceuticals Inc Stock (NRBO) Financials Data

NeuroBo Pharmaceuticals Inc (NRBO) Net Income 2023

NRBO net income (TTM) was -$11.83 million for the quarter ending September 30, 2023, a +14.69% increase year-over-year.
loading

NeuroBo Pharmaceuticals Inc (NRBO) Cash Flow 2023

NRBO recorded a free cash flow (TTM) of -$9.25 million for the quarter ending September 30, 2023, a +27.73% increase year-over-year.
loading

NeuroBo Pharmaceuticals Inc (NRBO) Earnings per Share 2023

NRBO earnings per share (TTM) was -$43.74 for the quarter ending September 30, 2023, a +65.16% growth year-over-year.
loading
NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company that develops and commercializes multimodal disease-modifying therapies for viral, neuropathic, and neurodegenerative diseases. It develops ANA001, a proprietary oral niclosamide formulation for the treatment of patients with moderate COVID-19; NB-01 for the treatment of painful diabetic neuropathy; NB-02 to treat the symptoms of cognitive impairment and modify the progression of neurodegenerative diseases associated with the malfunction of tau protein; and Gemcabene for various indications, including COVID-19 in combination with ANA001. NeuroBo Pharmaceuticals, Inc. is headquartered in Boston, Massachusetts.
$155.10
price up icon 0.86%
$91.24
price up icon 1.41%
$29.16
price up icon 0.17%
$157.65
price down icon 3.17%
$93.97
price up icon 0.43%
$409.52
price up icon 0.86%
Cap:     |  Volume (24h):